| BCBS Texas Medical Policies | Faricimab-svoa | 2026-01-01 |
| BCBS Texas Medical Policies | FDA - Drugs, Biologicals, Cellular and Gene Therapies | 2026-01-01 |
| BCBS Texas Medical Policies | Fetal Surgery for Prenatally Diagnosed Malformations | 2026-01-01 |
| BCBS Texas Medical Policies | Focal Treatments for Prostate Cancer | 2026-01-01 |
| BCBS Texas Medical Policies | Gastrointestinal Pathogen Panels | 2026-01-01 |
| BCBS Texas Medical Policies | Gender Assignment Surgery and Gender Reassignment | 2026-01-01 |
| BCBS Texas Medical Policies | Gene Therapies for Treatment of Wounds in Dystrophic | 2026-01-01 |
| BCBS Texas Medical Policies | Guselkumab | 2026-01-01 |
| BCBS Texas Medical Policies | Heart Transplant | 2026-01-01 |
| BCBS Texas Medical Policies | Heat and Cold Therapy Devices | 2026-01-01 |